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Background Vertigo and dizziness are often not fully
explained by an organic illness, but instead are related
to psychiatric disorders. This study aimed to evaluate
psychiatric comorbidity and assess psychosocial
impairment in a large sample of patients with a wide
range of unselected organic and non-organic (ie,
medically unexplained) vertigo/dizziness syndromes.
Methods This cross-sectional study involved a sample
of 547 patients recruited from a specialised
interdisciplinary treatment centre for vertigo/dizziness.
Diagnostic evaluation included standardised neurological
examinations, structured clinical interview for major
mental disorders (SCID-I) and self-report questionnaires
regarding dizziness, depression, anxiety, somatisation
and quality of life.
Results Neurological diagnostic workup revealed
organic and non-organic vertigo/dizziness in 80.8% and
19.2% of patients, respectively. In 48.8% of patients,
SCID-I led to the diagnosis of a current psychiatric
disorder, most frequently anxiety/phobic, somatoform
and affective disorders. In the organic vertigo/dizziness
group, 42.5% of patients, particularly those with
vestibular paroxysmia or vestibular migraine, had a
current psychiatric comorbidity. Patients with psychiatric
comorbidity reported more vertigo-related handicaps,
more depressive, anxiety and somatisation symptoms,
and lower psychological quality of life compared with
patients without psychiatric comorbidity.
Conclusions Almost half of patients with vertigo/
dizziness suffer from a psychiatric comorbidity. These
patients show more severe psychosocial impairment
compared with patients without psychiatric disorders.
The worst combination, in terms of vertigo-related
handicaps, is having non-organic vertigo/dizziness and
psychiatric comorbidity. This phenomenon should be
considered when diagnosing and treating vertigo/
dizziness in the early stages of the disease.
INTRODUCTION
Vertigo and dizziness, which have a lifetime preva-
lence of approximately 30%,1 are common symp-
toms presented to general practitioners and
neurologists.2 3 In approximately 30–50% of
patients with vertigo/dizziness, complaints are not
fully explained by a vestibular deficit or a defined
organic illness, but instead are related to psychiatric
disorders.4 5 In a sample of 189 patients with com-
plaints of vertigo/dizziness, 52.4% had medically
unexplained symptoms. In this group, vertigo/
dizziness was often associated with anxiety/phobic
(45.5%), somatoform (41.4%) or depressive disor-
ders (13.1%).4
Psychiatric comorbidity seems to be more preva-
lent in certain subgroups of organic vertigo/dizzi-
ness.6 For example, Eckhardt-Henn et al7 found that
in a sample of 68 patients with vertigo/dizziness,
those who suffered from vestibular migraine or
Meniere’s disease had significantly higher rates of
psychiatric comorbidity (65% and 57%, respect-
ively), particularly anxiety and depressive disorders,
compared with patients who suffered from vestibular
neuritis (22%) or benign paroxysmal positional
vertigo (BPPV) (15%). In a study of 59 patients
with vestibular disorders, patients with vestibular
migraine had the highest chance of psychiatric
comorbidity at a 1-year follow-up (58.5%).8 Thus,
prognosis may be poor in patients who suffer from
severe and relapsing vertigo attacks. Additional risk
factors may be negative beliefs about the conse-
quences of vertigo/dizziness, anxiety/panic-related
cognition or maladaptive coping strategies (eg, cata-
strophic thoughts, tendency to evaluate body sensa-
tions fearfully). By contrast, psychological well-being
and resilient coping protect against the development
of psychiatric comorbidity.5 8–10
Approximately 80% of patients with vertigo/diz-
ziness with a comorbid psychiatric disorder report
lower quality of life (QoL) than those without any
psychiatric comorbidity. These patients feel more
impaired in their daily lives or are unable to work
due to their vertigo/dizziness symptoms. Moreover,
patients with vertigo/dizziness with a comorbid psy-
chiatric disorder frequently use the healthcare
system.8 11 Given patients’ vertigo/dizziness-related
handicaps and associated costs for healthcare and
social systems, it is important to identify and effect-
ively treat these patients as early as possible.
Although previous studies show associations
between selected subgroups of patients with vertigo/
dizziness and psychiatric comorbidity,4 6 9 these
studies are based on small sample sizes and focus
only on selected organic vertigo/dizziness groups,
such as patients with vestibular migraine, Meniere’s
disease, BPPV or vestibular neuritis. Here we
evaluated psychiatric comorbidity in a large, non-
preselected sample of patients with either non-
organic or organic forms of vertigo/dizziness,
including diverse and incompletely explored
organic disorders (eg, vestibular paroxysmia).
Moreover, we investigated psychosocial impairment
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within these patients via self-report questionnaires on
vertigo-related handicaps and symptoms, anxiety, depression,
somatisation, and health-related QoL (HRQoL). Our hypotheses
were that (1) particular psychiatric comorbidities are more preva-
lent for specific vestibular disorders, and (2) patients with psychi-
atric comorbidity have greater psychosocial handicaps and
impairment compared with those without mental disorders after
controlling for age, sex and duration of vertigo/dizziness.
PATIENTS AND METHODS
Study design and sample
This cross-sectional study, conducted between May 2010 and
June 2012, involved 687 patients who gave informed consent
(from a total of 860 eligible patients). Reasons for refusal were
insufficient language skills, a lack of interest, blindness, cognitive
difficulties in filling out a questionnaire, feelings of excessive
demands or privacy concerns. Patients were recruited through
routine care appointments at the German Centre for Vertigo
and Balance Disorders at the University Hospital Munich,
Campus Großhadern. For organisational reasons (eg, living
outside of Munich or vomiting after caloric testing), not all
patients underwent a Structured Clinical Interview (SCID-I) to
assess mental disorders.12 Therefore, we only included and ana-
lysed data from the 547 patients (44.1% male, 54.8±16.0 years
of age) who were interviewed. There were no significant differ-
ences between patients who did and did not participate in the
SCID-I concerning age, sex, vertigo severity, vertigo-related
handicap, depression, anxiety, somatisation, or physical or psy-
chological HrQoL.
Nearly all (91.5%) patients suffered from vertigo/dizziness for
at least 3 months; 46.2% had vertigo/dizziness symptoms for
more than 3 months up to 2 years, and 45.3% had symptoms
for more than 2 years. Furthermore, 26.1% of patients had
taken medication (43.2% of patients with Meniere’s disease
received Betahistin), 7.5% practised liberatory manoeuvres,
4.8% received physiotherapeutic treatment, 4.2% had psycho-
therapy and 0.7% underwent surgery.
Patients were included if they were at least 18 years of age
and possessed sufficient German language skills. Exclusion cri-
teria were any of the following diagnoses: neurodegenerative
disorder (eg, dementia), schizoaffective or psychotic disorder,
substance abuse or severe suicidal tendencies. All patients were
informed about the aims of the study and gave written informed
consent. This study was approved by the Ethics Committee of
the University of Munich (ref. 108–10).13
Assessment and psychological instruments
Neurological diagnostic workup
All patients underwent structured history-taking and a systematic
and standardised physical examination by an expert medical scientist
at the German Centre for Vertigo and Balance Disorders, including
complete neurological, neuro-otological and neuro-ophthalmo-
logical examinations. Vestibular testing included the head impulse
test, measurement of subjective visual vertical and ocular torsion,
and caloric irrigation by video-oculography. The expert medical sci-
entist made a clinical diagnosis based on the results of examinations
according to diagnostic criteria.14 The diagnosis of vestibular
migraine was based on criteria from Neuhauser and Lempert,15 16
the diagnosis of Meniere’s disease was based on criteria from the
American Academy of Otolaryngology, Head, and Neck Surgery,17
and the diagnosis of vestibular paroxysmia, which is attributed to
neurovascular cross-compression and leads to vertiginous spells
often accompanied by unsteadiness in stance or gait, was based on
criteria from Brandt and Dieterich18 and Hüfner et al.19 The
co-occurrence of multiple organic vertigo/dizziness diagnoses was
possible. Based on the neurological diagnostic workup, the following
two groups emerged:
1. Patients with an organic or vestibular cause of vertigo/dizzi-
ness (ie, the presence of one or more of the above men-
tioned diagnoses, including those patients with a
combination of organic and non-organic causes of dizziness).
2. Patients with a non-organic or non-vestibular cause of vertigo/
dizziness (ie, medically unexplained vertigo/dizziness).
Psychometric examination: Structured Clinical Interview (SCID-I)
Clinical staff conducted SCID-I interviews to assess patients’
psychiatric disorders according to the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV) classifi-
cation system.12 The co-occurrence of multiple psychiatric diag-
noses was possible. All interviewers were initially blind to the
organic vs non-organic vertigo/dizziness diagnoses of patients,
that is, the SCID-I interviewers were not informed about any
potential diagnoses of these patients. If the interviewer sus-
pected a somatoform disorder due to vertigo/dizziness, this diag-
nosis was assigned only if the patient had been classified as
having non-organic vertigo/dizziness. All interviewers under-
went intensive training, including practice interviews with
patients who were not recruited for the study. Inter-rater reli-
ability was evaluated via interviews with a simulated patient; the
κ value was 0.94. Interviewers were required to undergo SCID-I
supervision led by a senior physician on a regular basis (ie,
every 3–4 weeks).
Patient self-report questionnaires
The Vertigo Handicap Questionnaire,20 the Vertigo Symptom
Scale,21 the revised Beck Depression Inventory,22 the Beck
Anxiety Inventory,23 the Patient Health Questionnaire24 and the
Short-Form Health Survey (SF-12) on HRQoL25 were com-
pleted by patients (table 1).
Statistical analysis
Statistical analysis was conducted using SPSS (V.21.0). To test
for differences among SCID-I participants and non-participants,
independent samples t tests were conducted; because of inflation
of α due to multiple comparisons, statistical significance level
was set at p<0.006 (0.05/8). To test for differences in self-
report questionnaire scores among vertigo/dizziness subgroups,
we computed descriptive statistics and performed χ2 tests and
analyses of variance controlled for sex, age and duration of
vertigo/dizziness. Due to inflation of α, statistical significance
level was set at p<0.002 (0.05/28) for χ2 tests and p<0.01
(0.05/8) for analyses of variance. When statistically significant
main effects were detected, we conducted Bonferroni post hoc
tests controlled for age and sex. Effect sizes (partial η2) were
computed and considered small if partial η2 was ≥0.01 and
<0.06, medium if partial η2 was ≥0.06 and <0.14, and large if
partial η2 was ≥0.14.26 To examine the relationship between
self-report questionnaire scores and the occurrence of psychi-
atric comorbidity, we conducted binary logistic regression ana-
lysis controlled for sex, age and duration of vertigo/dizziness.
The fit of the model was evaluated using the omnibus test of
coefficients (χ2, statistically significant if p<0.05) and the
Hosmer-Lemeshow statistic (χ2, good fit if p>0.05).27
RESULTS
Neurological diagnosis
Neurological diagnostic workup revealed organic vertigo/dizzi-
ness in 442 (80.8%) patients and non-organic (ie, medically
Neuropsychiatry
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unexplained) vertigo/dizziness in 105 (19.2%) patients. Among
patients with organic vertigo/dizziness, vestibular migraine was
the most frequent diagnosis (n=95), followed by BPPV (n=87),
Meniere’s disease (n=81), bilateral vestibulopathy (n=45), ves-
tibular paroxysmia (n=43), multisensory deficit (n=42), central
vertigo (n=38), vestibular neuritis (n=29), polyneuropathy
(n=26) and unilateral vestibular loss (n=20). Although most
(75.1%) patients had a single organic vertigo/dizziness diagnosis,
20.6% had two diagnoses, 3.6% had three diagnoses and 0.7%
had four diagnoses.
Prevalence of psychiatric comorbidity
Next, we analysed the prevalence of current psychiatric
comorbidity. SCID-1 using DSM-IV criteria led to a diagnosis
of current mental disorder in 48.8% of patients. Specifically,
158 (28.9%) patients had an anxiety/phobic disorder, 136
(24.9%) had a somatoform disorder, 104 (19.0%) had an affect-
ive disorder, 16 (2.9%) had a substance abuse disorder and 4
(0.7%) had an eating disorder. Some patients had more than
one psychiatric comorbidity; 42 patients (7.7%) had anxiety/
phobic and somatoform disorders, 32 (5.9%) had anxiety/
phobic and affective disorders, 21 (3.8%) had affective and
somatoform disorders and 20 (3.7%) had anxiety/phobic, affect-
ive and somatoform disorders.
Among patients with current anxiety/phobia, the most fre-
quent diagnosis was specific phobia (n=61), primarily of
heights, flying, or small and tight rooms, followed by agorapho-
bia without panic disorder (n=53), panic disorder with agora-
phobia (n=33), panic disorder without agoraphobia (n=24),
generalised anxiety disorder (n=16) and social phobia (n=10).
Combination of neurological and psychiatric diagnoses
When considering neurological diagnoses and psychiatric
comorbidities, four subgroups emerged: patients with organic
vertigo/dizziness and no psychiatric comorbidity (group o+/p−),
patients with non-organic vertigo/dizziness and no psychiatric
comorbidity (group o−/p−; ie, patients with disturbed well-being
on a subclinical level), patients with organic vertigo/dizziness
and psychiatric comorbidity (group o+/p+), and patients with
non-organic vertigo/dizziness and psychiatric comorbidity
(group o−/p+). The prevalence of psychiatric disorders was sig-
nificantly higher (χ2=45.9; df=1; p<0.001) among patients
with non-organic vertigo/dizziness (75.2%) than among patients
with organic vertigo/dizziness (42.5%) (table 2).
Most patients in subgroups o+/p− (48.7%), o−/p− (60.9%),
and o+/p+ (44.7%) suffered from vertigo/dizziness for between
3 months and 2 years, whereas most patients in subgroup o−/p+
had vertigo/dizziness for 2–10 years (46.3%). Furthermore, age
and sex differed significantly among the four subgroups (see
online supplementary table A1).
Psychiatric comorbidity in organic vertigo/dizziness
subgroups
In the organic vertigo/dizziness subgroup, 22 (51.2%) patients
with vestibular paroxysmia and 47 (49.5%) patients with ves-
tibular migraine had a current psychiatric comorbidity,
whereas only 11 (24.4%) of patients with bilateral vestibulo-
pathy fulfilled criteria for a current comorbid mental disorder.
Anxiety/phobic disorders were most frequent in patients with
vestibular paroxysmia (32.6%) or vestibular migraine (32.6%)
and least frequent in patients with bilateral vestibulopathy
Table 1 Overview and description of patients’ self-report questionnaire scores
Questionnaire Description Scores, scales Reliability (α) Validity
Vertigo Handicap Questionnaire
(VHQ)
▸ Assessment of physical and psychosocial
handicap due to vertigo/dizziness
▸ 25 items
▸ Five-point scale: 0 (never) to 4 (always)
Sum score ranging from 0 to 100 High (α=0.92) Good
construct
validity
Vertigo Symptom Scale (VSS) ▸ Assessment of frequency of dizziness-related
symptoms
▸ 34 items
▸ Five-point scale: 0 (never) to 4 (more than once
per week)
Two subscales: (I) vertigo and associated
symptoms (VSS-VER) and (II) somatic









▸ Assessment of depression severity during the last
2 weeks
▸ 21 items
▸ Four-point scale: 0–3
Sum score ranging from 0 to 63: ≤8, not








Beck Anxiety Inventory (BAI) ▸ Assessment of anxiety severity during the last
7 days
▸ 21 items
▸ Four-point scale: 0 (not at all) to 3 (strongly)
Sum score ranging from 0 to 63: ≤7, not
clinically relevant; 8–15, mild anxiety;







▸ Assessment of most important Diagnostic and
Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV) criteria for somatisation
disorders, and two items from the depression
module
▸ 15 items
▸ Three-point scale: 0 (not bothered at all) to 2
(bothered a lot/more than half of the time or
nearly every day)
Sum score ranging from 0 to 30:≤4,





Health-related quality of life
measure (HRQoL) Short-Form
Health Survey (SF-12)
▸ Assessment of HRQoL during the last 4 weeks
▸ 12 items
Physical and psychological HRQoL,
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(17.8%) or vestibular neuritis (17.2%). Affective disorders
occurred most frequently in patients with central vertigo
(23.7%) or BPPV (23.0%) and occurred least frequently in
patients with bilateral vestibulopathy (11.1%). Somatoform
disorders were most frequent in patients with vestibular
migraine (21.1%) and least frequent in patients with bilateral
vestibulopathy (8.9%) (table 3).
Differences in psychosocial impairment assessed by
self-report questionnaires
Overall, there were significant differences in subjective psycho-
social impairment and handicaps between patients with and
without psychiatric comorbidity (table 4). That is, compared
with patients with psychiatric comorbidity, patients with no psy-
chiatric comorbidity reported less vertigo-related handicaps,
fewer vertigo-related symptoms, less autonomic arousal, fewer
depressive, anxiety and somatisation symptoms, and higher psy-
chological HRQoL after controlling for age, sex and duration of
vertigo/dizziness. Effect sizes were clinically relevant (table 4,
see online supplementary tables A2 and A3). The worst combin-
ation, in terms of vertigo-related handicaps, was having non-
organic vertigo/dizziness and psychiatric comorbidity.
Finally, we found that vertigo-associated symptoms (Vertigo
Symptom Scale-VER: OR 1.8, 95% CI (1.1 to 2.9)), depression
(Beck Depression Inventory: OR 1.1, 95% CI (1.04 to 1.2)) and
anxiety (Beck Anxiety Inventory: OR 1.1, 95% CI (1.01 to 1.1))
increased the odds of having psychiatric comorbidity after control-
ling for age, sex and duration of vertigo/dizziness. The fit of the
model was good (omnibus test of coefficients: χ2=79.9; df=14;
p<0.001; Hosmer-Lemeshow statistic: χ2=12.3; df=8; p=0.14).
DISCUSSION
The aim of this study was to investigate psychiatric comorbidity in a
large, unselected sample of patients, who were referred to a specia-
lised, interdisciplinary treatment centre for vertigo/dizziness, which
allowed the inclusion and analysis of several previously unexplored
subgroups. We hypothesised that specific vestibular disorders are
associated with particular psychiatric comorbidities and that patients
with mental disorders have more psychosocial handicaps and
impairment compared with those without mental disorders after
controlling for age, sex and duration of vertigo/dizziness.
Our results support our first hypothesis. We found that spe-
cific psychiatric comorbidity was more prevalent in patients
with certain vestibular disorders. In particular, patients who suf-
fered from episodic vertigo/dizziness, namely vestibular paroxys-
mia or vestibular migraine, had the highest prevalence of
psychiatric disorders. The most frequent mental disorders in
patients with episodic vertigo/dizziness, such as vestibular
migraine, vestibular paroxysmia and Menière’s disease, were
phobias or anxiety, which is partly in line with previous
studies.6 7 Moreover, our results point towards patients with
vestibular paroxysmia as a particularly vulnerable subgroup. To
our knowledge, there have been no studies to date investigating
psychiatric comorbidity in patients with vestibular paroxysmia.
In episodic vertigo/dizziness conditions, such as vestibular
migraine and vestibular paroxysmia, patients may unexpectedly
experience intense and recurrent vertigo attacks, which might
be a particular burden for these patients. One hypothesis may
be that patients perceive the onset and intensity of vertigo/dizzi-
ness attacks as uncontrollable, which could trigger anxiety and
panic-related cognition and sometimes lead to the development
of avoidance behaviour.9 28 Previous studies also suggest a link
Table 2 Combination of neurological diagnosis with psychiatric comorbidity (n=547)
SCID-I
No psychiatric comorbidity Psychiatric comorbidity
Neurological diagnosis
Organic vertigo/dizziness 254 (57.5%) (group o+/p−) 188 (42.5%) (group o+/p+) 442 (80.8%)
Non-organic (ie, medically unexplained) vertigo/dizziness 26 (24.8%) (group o−/p−) 79 (75.2%) (group o−/p+) 105 (19.2%)
Group o+/p−, organic vertigo/dizziness without psychiatric comorbidity.
Group o−/p−, non-organic vertigo/dizziness without psychiatric comorbidity.
Group o+/p+, organic vertigo/dizziness with psychiatric comorbidity.
Group o−/p+, non-organic vertigo/dizziness with psychiatric comorbidity.
Table 3 Current psychiatric comorbidity in patients diagnosed with organic vertigo/dizziness (n=442) and differences among subgroups
SCID-I diagnosis*
Diagnoses of organic vertigo/dizziness
Subgroup





























Affective 16.3 14.7 21.4 23.0 23.7 16.0 17.2 11.1 BPPV>BV 12.5; 1 (<0.001)




*Multiple psychiatric diagnoses were possible.
BPPV, benign paroxysmal positional vertigo; BV, bilateral vestibulopathy; CV, central vertigo; MD, Meniere’s disease; MultD, multisensory deficit; VM, vestibular migraine; VN, vestibular
neuritis; VP, vestibular paroxysmia.
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between anxiety and balance disorders.29 Patients with phobic/
anxiety and vestibular disorders frequently exhibit avoidance
behaviour and report dizziness, spatial disorientation and
anxiety in particular environments.30 Increased visual depend-
ence (ie, the preferential use of vision for spatial orientation and
postural control) and subsequent increased body sway can be
observed in patients with primary vestibular disorders and those
with phobic/anxiety disorders.31 32 However, upon a closer
look, increased body sway differed in patients with vestibular
disorders from those with phobic/anxiety disorders. In patients
with vestibular disorders, the body sway increased in more diffi-
cult balance tasks, whereas in patients with phobic disorders, it
turned out that the more difficult the balance task was, the
better the balance performance occurred.33 Thus, ‘instability’
measured in patients with phobia may just be a matter of pos-
tural strategy rather than postural capability. Although the term
‘phobic postural vertigo’ is not a recognised DSM-IV/V or
International Classification of Diseases-10 diagnosis, it is a clin-
ically used concept describing a subgroup of patients with
certain characteristics, such as dizziness and postural imbalance
in particular situations (eg, in shopping centres) and with avoid-
ance behaviour.34 More generally, it has been suggested that the
association between vertigo/dizziness and anxiety may be
explained by neuroanatomical connections between the vestibu-
lar system and neuronal pathways that are involved in anxiety/
phobic conditioning and modulated by monoaminergic and nor-
adrenergic influences.29
We also found that affective disorders were most frequent in
patients with BPPV, central vertigo or multisensory deficits.
These vertigo/dizziness disorders are typically observed in older
patients and are often associated with feelings of depression.35
Furthermore, somatoform disorders were mainly diagnosed in
patients with vestibular migraine, which agrees with previous
studies.6 36
A second major finding in the present study was that nearly
half of the patients who were referred to a specialised, interdis-
ciplinary vertigo/dizziness treatment centre had a current psychi-
atric comorbidity according to the SCID-I, which is the gold
standard for diagnosing mental disorders and was conducted
blind to patient vestibular diagnosis.37 In agreement with previ-
ous studies,4 11 we found that anxiety and phobic disorders
were most frequent, followed by somatoform and affective dis-
orders. The prevalence of psychiatric disorders was significantly
higher in the non-organic vertigo/dizziness subgroup than in the
organic subgroup. Our results also support our second hypoth-
esis, as patients with psychiatric comorbidity reported more psy-
chosocial impairment, including more vertigo-related symptoms,
greater autonomic arousal, more depressive, anxiety and soma-
tisation symptoms, and lower psychological HRQoL, as com-
pared with patients without psychiatric comorbidity. With
Table 4 Differences among vertigo/dizziness subgroups in self-report questionnaire results after controlling for sex, age and duration of
vertigo/dizziness
Outcome Subgroups* Mean (±SD) F; df (p)† Post hoc comparison of subgroups (p); partial η2‡
VHQ—sum score o+/p− 39.8±17.0 12.0; 3 (<0.001) o+/p−< o+/p+ (<0.001); 0.04
o−/p− 31.9±15.8 o+/p−<o−/p+ (<0.001); 0.07
o+/p+ 47.9±17.3 o−/p−<o+/p+ (<0.001); 0.09
o−/p+ 50.9±15.1 o−/p−<o−/p+ (<0.001); 0.28
VSS—vertigo and associated symptoms o+/p− 1.0±0.7 7.1; 3 (<0.001) o+/p−<o+/p+ (<0.001); 0.07
o−/p− 0.8±0.4 o+/p−<o−/p+ (0.008); 0.05
o+/p+ 1.5±0.9 o−/p−<o+/p+ (0.003); 0.10
o−/p+ 1.5±1.0 o−/p−<o−/p+ (0.004); 0.17
VSS—autonomic arousal o+/p− 0.9±0.6 12.6; 3 (<0.001) o+/p−<o+/p+ (<0.001); 0.08
o−/p− 1.1±0.7 o+/p−<o−/p+ (<0.001); 0.08
o+/p+ 1.4±0.8
o−/p+ 1.4±0.6
BDI-2 o+/p− 8.0±5.5 25.7; 3 (<0.001) o+/p−<o+/p+ (<0.001); 0.17
o−/p− 9.7±8.5 o+/p−<o−/p+ (<0.001); 0.20
o+/p+ 15.3±10.0 o−/p−<o−/p+ (0.004); 0.12
o−/p+ 15.2±7.3
BAI o+/p− 9.6±7.2 23.9; 3 (<0.001) o+/p−<o+/p+ (<0.001); 0.13
o−/p− 9.3±5.4 o+/p−<o−/p+ (<0.001); 0.19
o+/p+ 17.0±10.9 o−/p−<o+/p+ (0.004); 0.06
o−/p+ 18.6±8.9 o−/p−<o−/p+ (<0.001); 0.20
PHQ-15 o+/p− 8.3±4.5 14.0; 3 (<0.001) o+/p−<o+/p+ (<0.001); 0.09
o−/p− 8.1±3.6 o+/p−<o−/p+ (<0.001); 0.10
o+/p+ 11.4±5.1
o−/p+ 11.9±4.7




SF-12—Psychological HRQoL o+/p− 53.0±9.0 8.6; 3 (<0.001) o+/p−>o+/p+ (<0.001); 0.03
o−/p− 52.8±11.1 o+/p−>o−/p+ (<0.001); 0.07
o+/p+ 48.6±13.0 o−/p−>o−/p+ (0.005); 0.08
o−/p+ 45.8±13.0
*Group o+/p−: n=(123; 254), group o−/p−: n=(14; 26); group o+/p+: n=(79; 188); group o−/p+: n=(38; 79).
†Adjusted statistical significance level, p<0.01; statistically significant results are in bold.
‡All comparisons are Bonferroni-adjusted; classification of effect sizes: italics: small if 0.01 ≤ partial η2<0.06; underlined: medium if 0.06 ≤ partial η2<0.14; bold: large if partial
η2≥0.14.
BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; HRQoL, health-related quality of life; PHQ-15, Patient Health Questionnaire; SF-12, Short-Form Health Survey; VHQ, Vertigo
Handicap Questionnaire; VSS, Vertigo Symptom Scale.
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respect to vertigo-related handicaps, the worst combination was
having non-organic vertigo/dizziness and psychiatric comorbid-
ity. These differences in self-reported complaints and symptoms
underscore the impairment and handicaps experienced by
people with vertigo/dizziness and psychiatric comorbidity.4 8 In
longitudinal studies, patients with mixed physical and psycho-
logical symptoms were found to be at risk of remaining symp-
tomatic and handicapped.38 However, we found no difference
between subgroups in physical HRQoL as measured by the
SF-12. Vertigo/dizziness-related QoL measures, however, may be
more sensitive and reliable than general physical HRQoL mea-
sures, such as the SF-12, as the former measures reflect the spe-
cific impact of vertigo/dizziness and associated symptoms.
Given the associations among vertigo/dizziness, comorbid psy-
chiatric disorders and self-reported impairment that may lead to
high costs for the healthcare and social systems, it is important
to identify and effectively treat these patients early.8 11 Our find-
ings illustrate the relevance of an interdisciplinary approach
when diagnosing patients with vertigo/dizziness. Psychological
counselling and psychotherapy should be included in the treat-
ment plan of these patients to address the predominant psychi-
atric problem, as there is preliminary evidence that
psychotherapy may be effective in patients with medically unex-
plained vertigo/dizziness.39
Our results are limited because the SCID-I does not consider
the aetiology of psychiatric disorders (ie, whether they are caused
by vertigo/dizziness). Although all interviewers underwent inten-
sive training and regularly attended supervision meetings, and
SCID inter-rater reliability is typically high, there may have been
systematic overdiagnosis or underdiagnosis as compared with
standard norms. Further, the study design was cross-sectional,
which does not allow for causal conclusions. The vestibular parox-
ysmia group may also be slightly contaminated by patients with
non-organic dizziness, as this diagnosis was based on patient
history, positive MRI for neurovascular cross-compression and
response to treatment with carbamazepine (ie, diagnostic criteria
as defined by Brandt and Dieterich and Hüfner et al).18 19 The
MRI criterion (ie, cross-compression) is very sensitive (<5% false
negative) but not very specific (>25% false positive),40 and in add-
ition, response to carbamazepine could be a placebo response.
Thus, there may be in some cases a slight overlap between the
‘organic’ and ‘non-organic’ groups. Furthermore, according to the
definition of somatoform disorders in the DSM-IV (SCID-I) we
used the term ‘medically unexplained vertigo/dizziness’ though it
may be problematic, particularly in regard to the concept of the
Somatic Symptom Disorder of the DSM-V. However, as the study
began in 2010, we used the SCID-I, which is based on the
DSM-IV—the valid diagnostic manual of that time. Our sample
was unselected and representative of a specialised tertiary care
department, rather than composed of all patients with vertigo/diz-
ziness. As most patients who present in tertiary care were previ-
ously treated by neurologists in secondary care settings, and as
only patients who do not adequately respond to previous treat-
ment approaches are referred to tertiary care, a selection bias must
be assumed (ie, some dizziness syndromes are missing).
Nevertheless, recruitment within a specialised tertiary care depart-
ment allowed us to include and investigate a wide range of organic
vertigo/dizziness subgroups, such as vestibular paroxysmia, which
had never been investigated until now. Additional strengths of this
study are that we examined a large sample of patients and used
extremely high international diagnostic standards. Different diag-
nostic approaches were also used, including clinical-neurological
examinations by experts at a tertiary referral centre, structured
interviews for assessing psychiatric disorders by trained clinical
staff, and patient self-report questionnaires concerning psycho-
social variables that were evaluated in light of diagnostic
subgroups.
In conclusion, our study supports previous findings that many
patients suffering from vertigo/dizziness also exhibit comorbid
psychiatric disorders, particularly anxiety and phobic disorders.6
In particular, we identified vestibular paroxysmia as an especially
vulnerable subgroup for the occurrence of comorbid psychiatric
disorders. Patients with vestibular migraine, vestibular paroxys-
mia or Meniere’s disease were frequently affected by anxiety/
phobic disorders, which may be explained by the uncontrollabil-
ity of vertigo/dizziness attacks in these conditions.28 Patients
with psychiatric comorbidity reported more psychosocial
impairment and greater handicaps as compared with patients
without psychiatric comorbidity, indicating the urgent need for
the early and effective detection and treatment of these
patients.39 41 Further research should focus on risk factors for
the development of psychiatric comorbidity subsequent to
organic vertigo/dizziness. Also, considering the high prevalence
rate of psychiatric comorbidity and the substantial impairment
and handicaps in patients with vertigo/dizziness, an internation-
ally accepted diagnostic classification that describes all aspects of
patients with psychiatric comorbidity should be developed and
implemented.
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